Privileging pleasure: Temazepam injection in a heroin marketplace

References 

1. Aitken C, Higgs P. Severe vein damage caused by temazepam injecting. Australian and New Zealand Journal of Public Health. 2002;26(1):79
   • MEDLINE
   • CrossRef
2. Aitken C, Moore D, Higgs P, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: evidence from the street. International Journal of Drug Policy. 2002;13:189–198
3. Albert E. Dealing with danger: The normalization of risk in cycling. International Review for the Sociology of Sport. 1999;34(2):157–171
4. Becker HS. Outsiders: Studies in the sociology of deviance. New York, London: The Free Press, Collier-MacMillan Limited; 1963;
5. Bellaby P, Lawrenson D. Approaches to the risks of riding motorcycles: Reflections on the problems of reconciling statistical risk-assessment and motorcyclists’ own reasons for riding. The Sociological Review. 2001;49(3):368–388
6. Bergschmidt VB. Pleasure, power and dangerous substances: Applying Foucault to the Study of ‘Heroin Dependence’ in Germany. Anthropology & Medicine. 2004;11(1):59–73
7. Bloor M. A user's guide to contrasting theories of HIV-related risk behaviour. In:  Gabe J editors. Medicine, health and risk: Sociological approaches. Malden, MA, US: Blackwell Publishing; 1995;p. 19–30
8. Bunton R. Knowledge, emobodiment and neo-liberal drug policy. Contemporary Drug Problems. 2001;28(2):221–243
9. Breen C, Degenhardt L, Bruno R, Roxburgh A, Jenkinson R. The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia. Medical Journal of Australia. 2004;181(6):300–304
10. Byrne, F. (1992). The community, the council and the police: A combination to reduce crime in Footscray. In AIC Conference Proceedings No. 15. Australian Institute of Criminology. Retrieved 18 July, 2004. www.aic.gov.au/conferences/natovcp/index.html.
11. Coveney J, Bunton R. In pursuit of the study of pleasure: implications for health research and practice. Health: An Interdisciplinary Journal for the Study of Health Illness and Medicine. 2003;7(2):161–179
12. Davis M. HIV prevention rationalities and serostatus in the risk narratives of gay men. Sexualities. 2002;5(3):281–299
13. Degenhardt, L., Day, C., Hall, W. (Eds.) (2004). The causes, course and consequences of the heroin shortage in Australia. NDLERF Monograph Series No. 3. Canberra: Commonwealth of Australia.
14. Dobbin M. Temazepam injecting in Victoria: Discussion paper. Melbourne: Department of Human Services, Victoria; 2001;
15. Dobbin M. The Victorian temazepam injection prevention initiative. Chief Health Officer's Bulletin. 2002;2(1):13–16
16. Dobbin M. Product discontinuation. Temazepam soft gel capsule formulation. Victorian Department of Human Services; 2004;(Mailing List Email)
17. Feeney G, Gibbs H. Digit loss following misuse of temazepam. Medical Journal of Australia. 2002;176:380
18. Gerostamoulos, J., Drummer, O. (2001). Heroin Deaths in Victoria. Report No. 4. Melbourne: Victorian Institute of Forensic Medicine & Department of Forensic Medicine, Monash University.
19. Jay M. Editorial: Why do people take drugs?. International Journal of Drug Policy. 1999;10(1):5–7
20. Keane H. Critiques of harm reduction, morality and the promise of human rights. International Journal of Drug Policy. 2003;14:227–232
21. Klein R. Cigarettes are sublime. Durham, London: Duke University Press; 1993;
22. Lack J. A history of Footscray. Melbourne: Hargreen Publishing & The City of Footscray; 1991;
23. Lupton D. The imperative of health: Public health and the regulated body. London, Thousand Oaks: SAGE Publications; 1995;
24. Lupton D, Tulloch J. ‘Life would be pretty dull without risk’: voluntary risk-taking and its pleasures. Health, Risk and Society. 2002;4(2):113–124
25. Maclean S. “It might be a scummy-arsed drug but it's a sick buzz”: chroming and pleasure. Contemporary Drug Problems. 2005;32(2):295–318
26. Maher L. Personal communication. Sydney: University of New South Wales; 2005;
27. MIMS (2003). Normison. Consumer Medicine Information, MIMS/MyDoctor. http://mims.hcn.net.au. Accessed: 12 April, 2007.
28. Moore D, Fraser S. Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine. 2006;62(12):3035–3047
29. O’Malley P, Valverde M. Pleasure, freedom and drugs: The Uses of ‘Pleasure’ in Liberal Governance of Drug and Alcohol Consumption. Sociology. 2004;38(1):25–42
30. Petersen A. Risk governance and the new public health. In:  Petersen A,  Bunton R editor. Foucault, health and medicine. London and New York: Routledge; 1997;p. 188–206
31. Phillips H. The pleasure-seekers. New Scientist. 2003;180(2146):36
32. Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 2002;13(2):85–94
33. Westhaver R. ‘Coming Out of Your Skin’: Circuit parties pleasure and the subject. Sexualities. 2005;8(3):347–374
34. Wilce H. Temazepam capsules: What was the problem?. Australian Prescriber. 2004;27:58–59